Metraipolis › archive › dc_19629699eded

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing — Europe PMC PMID:41646982

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41646982
DOI: 10.3389/fimmu.2025.1684597
License (as archived): solo-consultazione
Archived: 2026-11-06T16:06:22.327Z
SHA-256 of the archived text: 14f312e119ca18991c357806b10d46c7ad5407d35505ef7158f561dabbec33dc
Stable URL of this page: https://metraipolis.com/documento/dc_19629699eded

How to cite

Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing — Europe PMC PMID:41646982 — Europe PMC (en), https://europepmc.org/article/MED/41646982 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19629699eded (Metraipolis archive dc_19629699eded, sha256 14f312e119ca18991c357806b10d46c7ad5407d35505ef7158f561dabbec33dc)

BibTeX

@misc{dc19629699eded,
  title = {Advances in immunotherapy for bladder cancer and clinical practice of next-generation sequencing — Europe PMC PMID:41646982},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41646982},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19629699eded; sha256 14f312e119ca18991c357806b10d46c7ad5407d35505ef7158f561dabbec33dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41646982. Agents can read the archived copy with the MCP tool read_document.